BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21404316)

  • 1. Semiparametric estimation for joint modeling of colorectal cancer risk and functional biomarkers measured with errors.
    Long Q; Zhang X; Bostick RM
    Biom J; 2011 May; 53(3):393-410. PubMed ID: 21404316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Coexpression of KITENIN and the ErbB4 CYT-2 Isoform Promotes the Transition from Colon Adenoma to Carcinoma Following APC loss.
    Bae JA; Kho DH; Sun EG; Ko YS; Yoon S; Lee KH; Ahn KY; Lee JH; Joo YE; Chung IJ; Lee SH; Kim H; Kim KK
    Clin Cancer Res; 2016 Mar; 22(5):1284-94. PubMed ID: 26527747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysplastic Aberrant Crypt Foci: Biomarkers of Early Colorectal Neoplasia and Response to Preventive Intervention.
    Clapper ML; Chang WL; Cooper HS
    Cancer Prev Res (Phila); 2020 Mar; 13(3):229-240. PubMed ID: 32132117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamin D and calcium on expression of MSH2 and transforming growth factors in normal-appearing colorectal mucosa of sporadic colorectal adenoma patients: A randomized clinical trial.
    Kwan AK; Um CY; Rutherford RE; Seabrook ME; Barry EL; Fedirko V; Baron JA; Bostick RM
    Mol Carcinog; 2019 Apr; 58(4):511-523. PubMed ID: 30499618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study.
    Peterova E; Bures J; Moravkova P; Kohoutova D
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33466593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Application of Structural Equation Modeling Estimates the Association between Oxidative Stress and Colorectal Adenoma.
    Eldridge RC; Goodman M; Bostick RM; Fedirko V; Gross M; Thyagarajan B; Flanders WD
    Cancer Prev Res (Phila); 2018 Jan; 11(1):52-58. PubMed ID: 29074536
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrant crypt foci as predictors of colorectal neoplasia on repeat colonoscopy.
    Anderson JC; Swede H; Rustagi T; Protiva P; Pleau D; Brenner BM; Rajan TV; Heinen CD; Levine JB; Rosenberg DW
    Cancer Causes Control; 2012 Feb; 23(2):355-61. PubMed ID: 22187142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
    Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
    Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal Aberrant Crypt Foci in Humans Are Not Surrogate Markers for Colorectal Cancer Risk.
    Quintanilla I; López-Cerón M; Jimeno M; Cuatrecasas M; Zabalza M; Moreira L; Alonso V; Rodríguez de Miguel C; Muñoz J; Castellvi-Bel S; Llach J; Castells A; Balaguer F; Camps J; Pellisé M
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00047. PubMed ID: 31136360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
    Lin MT; Zheng G; Tseng LH; Zhang P; Ling H; Azad N; Gocke CD; Montgomery E; Eshleman JR
    Hum Pathol; 2020 Apr; 98():120-128. PubMed ID: 32171651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MutL-homolog 1 expression and risk of incident, sporadic colorectal adenoma: search for prospective biomarkers of risk for colorectal cancer.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Cohen VL; Dash C; Seabrook ME; Fedirko V
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1599-609. PubMed ID: 19423536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling clinical outcome using multiple correlated functional biomarkers: A Bayesian approach.
    Long Q; Zhang X; Zhao Y; Johnson BA; Bostick RM
    Stat Methods Med Res; 2016 Apr; 25(2):520-37. PubMed ID: 23070593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The roles of JK-1 (FAM134B) expressions in colorectal cancer.
    Kasem K; Gopalan V; Salajegheh A; Lu CT; Smith RA; Lam AK
    Exp Cell Res; 2014 Aug; 326(1):166-73. PubMed ID: 24973512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.
    Toiyama Y; Inoue Y; Yasuda H; Saigusa S; Yokoe T; Okugawa Y; Tanaka K; Miki C; Kusunoki M
    J Gastroenterol; 2011 Feb; 46(2):153-63. PubMed ID: 20824289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of the APC/β-catenin signaling pathway as potential treatable, preneoplastic biomarkers of risk for colorectal neoplasms.
    Ahearn TU; Shaukat A; Flanders WD; Seabrook ME; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):969-79. PubMed ID: 22539608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer.
    Galamb O; Kalmár A; Péterfia B; Csabai I; Bodor A; Ribli D; Krenács T; Patai ÁV; Wichmann B; Barták BK; Tóth K; Valcz G; Spisák S; Tulassay Z; Molnár B
    Epigenetics; 2016 Aug; 11(8):588-602. PubMed ID: 27245242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal mucosal expression of MSH2 as a potential biomarker of risk for colorectal neoplasms.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Seabrook ME
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2965-73. PubMed ID: 19861524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of calcium and vitamin D on MLH1 and MSH2 expression in rectal mucosa of sporadic colorectal adenoma patients.
    Sidelnikov E; Bostick RM; Flanders WD; Long Q; Fedirko V; Shaukat A; Daniel CR; Rutherford RE
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1022-32. PubMed ID: 20332274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients.
    Gao Y; Um CY; Fedirko V; Rutherford RE; Seabrook ME; Barry EL; Baron JA; Bostick RM
    PLoS One; 2018; 13(12):e0208762. PubMed ID: 30557404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.